1	STOCKHOLM	stockholm	NNP	p2=NN	8	npadvmod	8:AM-TMP
2	(	(	-LRB-	_	3	punct	_
3	Reuters	reuters	NNP	_	1	appos	_
4	)	)	-RRB-	_	3	punct	_
5	-	-	:	p2=,	8	punct	_
6	Swedish	swedish	JJ	p2=NNP	7	amod	_
7	ministers	minister	NNS	_	8	nsubj	8:A0=PAG;36:A0=PAG
8	launched	launch	VBD	pb=launch.01	0	root	_
9	a	a	DT	_	10	det	_
10	fightback	fightback	NN	_	8	dobj	8:A1=PPT
11	on	on	IN	_	8	prep	8:AM-TMP
12	Friday	friday	NNP	_	11	pobj	_
13	against	against	IN	_	8	prep	_
14	U.S.	u.s.	NNP	_	16	nn	_
15	drugmaker	drugmaker	NNP	p2=NN	16	nn	_
16	Pfizer	pfizer	NNP	_	19	poss	_
17	's	's	POS	_	16	possessive	_
18	proposed	propose	VBN	p2=JJ|pb=propose.01	19	amod	_
19	takeover	takeover	NN	_	13	pobj	18:A1=PPT
20	of	of	IN	_	19	prep	_
21	AstraZeneca	astrazeneca	NNP	_	20	pobj	24:A0=PAG
22	,	,	,	_	21	punct	_
23	which	which	WDT	_	24	nsubj	24:R-A0
24	has	have	VBZ	pb=have.03	21	rcmod	_
25	half	half	PDT	p2=VBN	27	predet	_
26	its	its	PRP$	_	27	poss	_
27	roots	root	NNS	_	24	dobj	24:A1=PPT
28	and	and	CC	_	27	cc	_
29	more	more	JJR	_	31	amod	_
30	than	than	IN	_	31	quantmod	_
31	5,000	0	CD	_	32	num	_
32	staff	staff	NN	_	27	conj	_
33	in	in	IN	_	32	prep	_
34	Sweden	sweden	NNP	_	33	pobj	_
35	,	,	,	_	8	punct	_
36	highlighting	highlight	VBG	pb=highlight.01	8	advcl	8:AM-ADV
37	the	the	DT	_	38	det	_
38	risks	risk	NNS	_	36	dobj	36:A1=PPT
39	to	to	IN	_	38	prep	_
40	jobs	job	NNS	_	39	pobj	_
41	and	and	CC	_	40	cc	_
42	science	science	NN	_	40	conj	_
43	.	.	.	_	8	punct	_

1	Finance	finance	NNP	p2=VB	2	nn	_
2	Minister	minister	NNP	_	4	nn	_
3	Anders	anders	NNP	_	4	nn	_
4	Borg	borg	NNP	_	15	nsubj	15:A0
5	,	,	,	_	4	punct	_
6	Enterprise	enterprise	NNP	_	7	nn	_
7	Minister	minister	NNP	_	9	nn	_
8	Annie	annie	NNP	_	9	nn	_
9	Loof	loof	NNP	_	4	conj	_
10	and	and	CC	_	9	cc	_
11	Education	education	NNP	_	12	nn	_
12	Minister	minister	NNP	_	14	nn	_
13	Jan	jan	NNP	_	14	nn	_
14	Bjorklund	bjorklund	NNP	_	9	conj	_
15	said	say	VBD	pb=say.01	0	root	_
16	AstraZeneca	astrazeneca	NNP	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	shareholders	shareholder	NNS	_	22	nsubj	22:A0=PAG;23:A0=PAG
19	should	should	MD	_	22	aux	22:AM-MOD
20	"	"	``	_	22	punct	_
21	seriously	seriously	RB	_	22	advmod	22:AM-MNR
22	consider	consider	VB	pb=consider.01	15	ccomp	15:A1=PPT
23	rejecting	reject	VBG	pb=reject.01	22	xcomp	22:A1
24	"	"	``	_	23	punct	_
25	Pfizer	pfizer	NNP	_	27	poss	_
26	's	's	POS	_	25	possessive	_
27	plan	plan	NN	_	23	dobj	23:A1=PPT
28	,	,	,	_	22	punct	_
29	unless	unless	IN	_	31	mark	_
30	there	there	EX	_	31	expl	_
31	was	be	VBD	pb=be.02	22	advcl	22:AM-ADV
32	clarity	clarity	NN	_	31	attr	31:A1=PPT
33	on	on	IN	_	32	prep	_
34	its	its	PRP$	_	35	poss	_
35	impact	impact	NN	_	33	pobj	_
36	.	.	.	_	15	punct	_

1	AstraZeneca	astrazeneca	NNP	_	17	nsubj	17:A0=PAG;5:A1=PPT
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	5	nsubjpass	5:R-A1
4	was	be	VBD	_	5	auxpass	_
5	formed	form	VBN	pb=form.01	1	rcmod	_
6	from	from	IN	_	5	prep	5:A2=VSP
7	an	an	DT	_	11	det	_
8	Anglo	anglo	JJ	p2=NNP	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	Swedish	swedish	JJ	_	11	amod	_
11	merger	merger	NN	_	6	pobj	_
12	15	0	CD	_	13	num	_
13	years	year	NNS	_	14	npadvmod	_
14	ago	ago	RB	_	11	advmod	_
15	,	,	,	_	17	punct	_
16	has	have	VBZ	_	17	aux	_
17	rebuffed	rebuff	VBN	pb=rebuff.01	0	root	_
18	Pfizer	pfizer	NNP	_	21	poss	_
19	's	's	POS	_	18	possessive	_
20	current	current	JJ	p2=NN	21	amod	_
21	offer	offer	NN	_	17	dobj	17:A1=PPT
22	but	but	CC	_	17	cc	_
23	the	the	DT	_	25	det	_
24	U.S.	u.s.	NNP	_	25	nn	_
25	group	group	NN	_	28	nsubjpass	28:A1=PPT;30:A1=PPT
26	is	be	VBZ	_	28	auxpass	_
27	widely	widely	RB	_	28	advmod	28:AM-MNR
28	expected	expect	VBN	pb=expect.01	17	conj	_
29	to	to	TO	_	30	aux	_
30	return	return	VB	pb=return.01	28	xcomp	28:C-A1
31	with	with	IN	_	30	prep	30:AM-MNR
32	a	a	DT	_	34	det	_
33	sweetened	sweeten	VBN	pb=sweeten.02	34	amod	_
34	bid	bid	NN	p2=VBN	31	pobj	33:A1=PPT
35	.	.	.	_	28	punct	_

1	AstraZeneca	astrazeneca	NNP	_	4	poss	_
2	's	's	POS	_	1	possessive	_
3	chief	chief	JJ	_	4	amod	_
4	executive	executive	NN	_	7	nsubj	7:A0=PAG
5	has	have	VBZ	_	7	aux	_
6	not	not	RB	_	7	neg	7:AM-NEG
7	ruled	rule	VBN	pb=rule.02	0	root	_
8	out	out	RP	_	7	prt	7:C-V
9	discussions	discussion	NNS	_	7	dobj	7:A1=PPT
10	at	at	IN	_	9	prep	_
11	the	the	DT	_	13	det	_
12	right	right	JJ	_	13	amod	_
13	price	price	NN	_	10	pobj	_
14	.	.	.	_	7	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	given	give	VBN	pb=give.01	0	root	_
4	a	a	DT	_	8	det	_
5	five	#crd#	CD	_	7	hmod	_
6	-	-	HYPH	_	7	hyph	_
7	year	year	NN	_	8	nn	_
8	promise	promise	NN	p2=VBP	3	dobj	3:A1=PPT
9	to	to	TO	_	10	aux	_
10	have	have	VB	pb=have.03	8	infmod	_
11	20	0	CD	_	12	num	_
12	percent	percent	NN	_	10	dobj	10:A1=PPT
13	of	of	IN	_	12	prep	_
14	its	its	PRP$	_	16	poss	_
15	research	research	NN	_	16	nn	_
16	staff	staff	NN	_	13	pobj	_
17	in	in	IN	_	10	prep	10:AM-LOC
18	Britain	britain	NNP	_	17	pobj	22:AM-LOC
19	,	,	,	_	18	punct	_
20	where	where	WRB	_	22	advmod	22:R-AM-LOC
21	AstraZeneca	astrazeneca	NNP	_	22	nsubj	22:A0=PAG
22	has	have	VBZ	pb=have.03	18	rcmod	_
23	its	its	PRP$	_	24	poss	_
24	headquarters	headquarter	NNS	p2=NN	22	dobj	22:A1=PPT
25	,	,	,	_	3	punct	_
26	but	but	CC	_	3	cc	_
27	it	it	PRP	_	30	nsubj	30:A0=PAG
28	has	have	VBZ	_	30	aux	_
29	not	not	RB	_	30	neg	30:AM-NEG
30	spelt	spell	VBN	p2=VB|pb=spell.03	3	conj	_
31	out	out	RP	_	30	prt	30:C-V
32	what	what	WP	_	34	dobj	34:R-A1
33	this	this	DT	_	34	nsubj	34:A0=PAG
34	means	mean	VBZ	pb=mean.01	30	ccomp	30:A1=PPT
35	in	in	IN	_	34	prep	34:AM-LOC
36	absolute	absolute	JJ	_	37	amod	_
37	numbers	number	NNS	_	35	pobj	_
38	.	.	.	_	30	punct	_

1	At	at	IN	_	10	prep	10:AM-TMP
2	the	the	DT	_	4	det	_
3	same	same	JJ	_	4	amod	_
4	time	time	NN	_	1	pobj	_
5	,	,	,	_	10	punct	_
6	the	the	DT	_	8	det	_
7	U.S.	u.s.	NNP	_	8	nn	_
8	company	company	NN	_	10	nsubj	10:A0
9	has	have	VBZ	_	10	aux	_
10	said	say	VBN	pb=say.01	0	root	_
11	that	that	IN	_	21	complm	_
12	the	the	DT	_	15	det	_
13	overall	overall	JJ	_	15	amod	_
14	research	research	NN	_	15	nn	_
15	budget	budget	NN	_	21	nsubj	21:A1=PPT
16	of	of	IN	_	15	prep	_
17	a	a	DT	_	19	det	_
18	merged	merged	JJ	p2=VBN	19	amod	_
19	group	group	NN	_	16	pobj	_
20	would	would	MD	_	21	aux	21:AM-MOD
21	be	be	VB	pb=be.01	10	ccomp	10:A1=PPT
22	lower	low	JJR	_	21	acomp	21:A2=PRD
23	than	than	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	sum	sum	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	the	the	DT	_	29	det	_
28	two	#crd#	CD	_	29	num	_
29	companies	company	NNS	_	33	poss	_
30	'	'	POS	_	29	possessive	_
31	individual	individual	JJ	p2=NN	33	amod	_
32	research	research	NN	_	33	nn	_
33	budgets	budget	NNS	_	26	pobj	_
34	.	.	.	_	10	punct	_

1	The	the	DT	_	2	det	_
2	numbers	number	NNS	_	3	nsubj	3:A0=PAG
3	suggest	suggest	VBP	pb=suggest.01	0	root	_
4	Sweden	sweden	NNP	_	5	nsubj	5:A1=PPT;8:A1=PPT
5	is	be	VBZ	pb=be.01	3	ccomp	3:A1=PPT
6	right	right	JJ	_	5	acomp	5:A2=PRD
7	to	to	TO	_	8	aux	_
8	be	be	VB	pb=be.01	6	xcomp	_
9	worried	worried	JJ	p2=VBN	8	acomp	8:A2=PRD
10	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	currently	currently	RB	_	3	advmod	3:AM-TMP
3	has	have	VBZ	pb=have.03	0	root	_
4	around	around	IN	p2=RB	5	quantmod	_
5	11,000	0	CD	_	6	num	_
6	staff	staff	NN	_	3	dobj	7:A0=PAG;3:A1=PPT
7	working	work	VBG	pb=work.01	6	partmod	_
8	in	in	IN	_	7	prep	7:AM-LOC
9	research	research	NN	_	8	pobj	_
10	worldwide	worldwide	RB	_	7	advmod	7:AM-LOC
11	,	,	,	_	3	punct	_
12	while	while	IN	_	14	mark	_
13	AstraZeneca	astrazeneca	NNP	_	14	nsubj	14:A0=PAG
14	has	have	VBZ	pb=have.03	3	advcl	3:AM-ADV
15	9,000	0	CD	_	14	dobj	14:A1=PPT
16	,	,	,	_	3	punct	_
17	and	and	CC	_	3	cc	_
18	the	the	DT	_	20	det	_
19	two	#crd#	CD	_	20	num	_
20	companies	company	NNS	_	22	nsubj	22:A0=PAG
21	together	together	RB	_	22	advmod	22:AM-TMP
22	employ	employ	VBP	p2=VB|pb=employ.01	3	conj	_
23	3,450	0	CD	_	22	dobj	22:A1=PPT
24	in	in	IN	_	22	prep	22:AM-TMP
25	Britain	britain	NNP	_	27	hmod	_
26	-	-	HYPH	p2=,	27	hyph	_
27	2,600	0	CD	p2=NNP	24	pobj	_
28	at	at	IN	_	22	prep	22:AM-LOC
29	AstraZeneca	astrazeneca	NNP	_	28	pobj	_
30	and	and	CC	_	22	cc	_
31	850	0	CD	_	22	conj	_
32	at	at	IN	_	31	prep	_
33	Pfizer	pfizer	NNP	_	35	hmod	_
34	-	-	HYPH	p2=:	35	hyph	_
35	representing	represent	VBG	_	37	amod	_
36	17.25	0	CD	_	37	num	_
37	percent	percent	NN	_	32	pobj	_
38	of	of	IN	_	37	prep	_
39	the	the	DT	_	41	det	_
40	combined	combine	VBN	p2=JJ|pb=combine.01	41	amod	_
41	total	total	NN	p2=JJ	38	pobj	40:A1=PPT
42	.	.	.	_	22	punct	_

1	But	but	CC	_	3	cc	3:AM-DIS
2	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PAG;5:A0=DIR;21:A0=PAG
3	plans	plan	VBZ	p2=NNS|pb=plan.01	0	root	_
4	to	to	TO	_	5	aux	_
5	shed	shed	VB	p2=VBD|pb=shed.01	3	xcomp	3:A1=PPT
6	400	0	CD	_	8	num	_
7	research	research	NN	_	8	nn	_
8	posts	post	NNS	_	5	dobj	5:A1=PPT
9	by	by	IN	_	5	prep	5:AM-TMP
10	2016	0	CD	_	9	pobj	_
11	as	as	IN	_	13	mark	_
12	it	it	PRP	_	13	nsubj	13:A1=PPT
13	moves	move	VBZ	pb=move.01	5	advcl	5:AM-TMP
14	to	to	IN	_	13	prep	13:A2=GOL
15	a	a	DT	_	17	det	_
16	new	new	JJ	_	17	amod	_
17	site	site	NN	_	14	pobj	_
18	in	in	IN	_	17	prep	_
19	Cambridge	cambridge	NNP	_	18	pobj	_
20	,	,	,	_	5	punct	_
21	suggesting	suggest	VBG	pb=suggest.01	5	advcl	_
22	that	that	IN	_	32	complm	_
23	research	research	NN	_	24	nn	_
24	centers	center	NNS	_	32	nsubj	34:A0
25	in	in	IN	_	24	prep	_
26	Sweden	sweden	NNP	_	25	pobj	_
27	and	and	CC	_	26	cc	_
28	the	the	DT	_	30	det	_
29	United	united	NNP	_	30	nn	_
30	States	states	NNP	p2=NNPS	26	conj	_
31	will	will	MD	_	32	aux	32:AM-MOD
32	have	have	VB	pb=have.02	21	ccomp	21:A1=PPT
33	to	to	TO	_	34	aux	_
34	take	take	VB	pb=take.01	32	xcomp	_
35	a	a	DT	_	37	det	_
36	larger	large	JJR	_	37	amod	_
37	share	share	NN	_	34	dobj	34:A1=PPT
38	of	of	IN	_	37	prep	_
39	future	future	JJ	p2=NN	41	amod	_
40	job	job	NN	_	41	nn	_
41	cuts	cut	NNS	p2=VBZ	38	pobj	_
42	if	if	IN	_	44	mark	_
43	Pfizer	pfizer	NNP	_	44	nsubj	46:A0=PAG;44:A1=PPT
44	is	be	VBZ	pb=be.01	32	advcl	_
45	to	to	TO	_	46	aux	_
46	hit	hit	VB	pb=hit.02	44	xcomp	44:A2=PRD
47	its	its	PRP$	_	50	poss	_
48	20	0	CD	_	49	num	_
49	percent	percent	NN	_	50	nn	_
50	target	target	NN	_	46	dobj	46:A1=GOL
51	.	.	.	_	3	punct	_

1	In	in	IN	_	5	prep	5:AM-LOC
2	Sweden	sweden	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG
5	employs	employ	VBZ	pb=employ.01	0	root	_
6	5,900	0	CD	_	7	num	_
7	people	people	NNS	_	5	dobj	5:A1=PPT
8	,	,	,	_	7	punct	_
9	of	of	IN	_	4	prep	_
10	whom	whom	WP	_	9	pobj	_
11	2,200	0	CD	_	12	num	_
12	work	work	NN	p2=VBP	5	dobj	_
13	in	in	IN	_	12	prep	_
14	research	research	NN	_	13	pobj	_
15	and	and	CC	_	14	cc	_
16	development	development	NN	_	14	conj	_
17	(	(	-LRB-	_	18	punct	_
18	R&D	r&d	NN	p2=NNP	12	appos	_
19	)	)	-RRB-	_	18	punct	_
20	,	,	,	_	12	punct	_
21	representing	represent	VBG	pb=represent.01	12	partmod	_
22	25	0	CD	_	23	num	_
23	percent	percent	NN	_	21	dobj	21:A1=PPT
24	of	of	IN	_	23	prep	_
25	the	the	DT	_	27	det	_
26	independent	independent	JJ	_	27	amod	_
27	company	company	NN	_	30	poss	_
28	's	's	POS	_	27	possessive	_
29	R&D	r&d	NN	p2=NNP	30	nn	_
30	total	total	NN	p2=JJ	24	pobj	_
31	.	.	.	_	5	punct	_

1	Sweden	sweden	NNP	_	6	nsubj	9:A0=PAG;6:A1=PPT
2	has	have	VBZ	_	6	aux	_
3	in	in	IN	_	6	prep	6:AM-TMP
4	the	the	DT	_	5	det	_
5	past	past	NN	_	3	pobj	_
6	been	be	VBN	pb=be.01	25	ccomp	25:A1=PPT
7	reluctant	reluctant	JJ	_	6	acomp	6:A2=PRD
8	to	to	TO	_	9	aux	_
9	agree	agree	VB	pb=agree.01	7	xcomp	_
10	to	to	IN	_	9	prep	9:A1=PPT
11	European	european	NNP	_	12	nn	_
12	Union	union	NNP	_	13	nn	_
13	rules	rule	NNS	p2=VBZ	10	pobj	16:A0=PAG
14	that	that	WDT	_	16	nsubj	16:R-A0
15	would	would	MD	_	16	aux	16:AM-MOD
16	require	require	VB	pb=require.01	13	rcmod	_
17	public	public	JJ	_	18	amod	_
18	interest	interest	NN	_	19	nn	_
19	tests	test	NNS	_	16	dobj	16:A1=PPT
20	for	for	IN	_	19	prep	_
21	business	business	NN	_	22	nn	_
22	deals	deal	NNS	_	20	pobj	_
23	but	but	CC	_	16	cc	_
24	Borg	borg	NNP	_	25	nsubj	25:A0
25	said	say	VBD	pb=say.01	0	root	_
26	Pfizer	pfizer	NNP	_	30	poss	_
27	's	's	POS	_	26	possessive	_
28	"	"	``	_	30	punct	_
29	semi-hostile	semi-hostile	JJ	p2=NN	30	amod	_
30	bid	bid	NN	_	33	nsubj	33:A0=PAG
31	"	"	''	_	30	punct	_
32	might	might	MD	_	33	aux	33:AM-MOD
33	force	force	VB	pb=force.02	25	ccomp	_
34	a	a	DT	_	35	det	_
35	rethink	rethink	NN	p2=VB	33	dobj	33:A1=PPT
36	.	.	.	_	25	punct	_

1	"	"	``	_	5	punct	_
2	Essentially	essentially	RB	_	5	advmod	_
3	,	,	,	_	5	punct	_
4	we	we	PRP	_	5	nsubj	5:A0=PAG;7:A0=PAG
5	want	want	VBP	pb=want.01	41	ccomp	41:A1=PPT
6	to	to	TO	_	7	aux	_
7	retain	retain	VB	pb=retain.01	5	xcomp	5:A1=PPT
8	an	an	DT	_	10	det	_
9	open	open	JJ	_	10	amod	_
10	regime	regime	NN	_	7	dobj	7:A1=PPT
11	,	,	,	_	5	punct	_
12	but	but	CC	_	5	cc	_
13	at	at	IN	_	31	prep	31:AM-TMP
14	the	the	DT	_	16	det	_
15	same	same	JJ	_	16	amod	_
16	time	time	NN	_	13	pobj	_
17	,	,	,	_	31	punct	_
18	if	if	IN	_	20	mark	_
19	you	you	PRP	_	20	nsubj	20:A0=PAG
20	behave	behave	VBP	pb=behave.01	31	advcl	31:AM-ADV
21	in	in	IN	_	20	prep	20:A1=PRD
22	the	the	DT	_	23	det	_
23	way	way	NN	_	21	pobj	27:AM-MNR
24	that	that	WDT	p2=WRB	27	dobj	27:R-A1
25	Pfizer	pfizer	NNP	_	27	nsubj	27:A0=PAG
26	is	be	VBZ	_	27	aux	_
27	doing	do	VBG	pb=do.02	23	rcmod	_
28	,	,	,	_	31	punct	_
29	then	then	RB	_	31	advmod	31:AM-TMP
30	you	you	PRP	_	31	nsubj	31:A0=PAG
31	undermine	undermine	VBP	pb=undermine.01	5	conj	_
32	the	the	DT	_	33	det	_
33	legitimacy	legitimacy	NN	_	31	dobj	31:A1=PPT
34	of	of	IN	_	33	prep	_
35	that	that	DT	_	37	det	_
36	open	open	JJ	_	37	amod	_
37	regime	regime	NN	_	34	pobj	_
38	,	,	,	_	41	punct	_
39	"	"	''	_	41	punct	_
40	he	he	PRP	_	41	nsubj	41:A0=PAG
41	told	tell	VBD	pb=tell.01	0	root	_
42	reporters	reporter	NNS	_	41	dobj	41:A2=GOL
43	.	.	.	_	41	punct	_

1	Borg	borg	NNP	_	14	nsubj	14:A0=PAG
2	,	,	,	_	1	punct	_
3	Prime	prime	NNP	_	4	nn	_
4	Minister	minister	NNP	_	6	nn	_
5	Fredrik	fredrik	NNP	_	6	nn	_
6	Reinfeldt	reinfeldt	NNP	_	1	conj	_
7	and	and	CC	_	6	cc	_
8	opposition	opposition	NN	_	9	nn	_
9	leader	leader	NN	_	11	nn	_
10	Stefan	stefan	NNP	_	11	nn	_
11	Lofven	lofven	NNP	_	6	conj	_
12	have	have	VBP	_	14	aux	_
13	previously	previously	RB	_	14	advmod	14:AM-TMP
14	expressed	express	VBN	pb=express.01	0	root	_
15	fears	fear	NNS	p2=VBZ	14	dobj	14:A1=PPT
16	the	the	DT	_	20	det	_
17	$	$	$	_	19	quantmod	_
18	106	0	CD	_	19	number	_
19	billion	#crd#	CD	_	20	nn	_
20	approach	approach	NN	_	22	nsubj	22:A0=PAG
21	would	would	MD	_	22	aux	22:AM-MOD
22	lead	lead	VB	pb=lead.03	15	ccomp	_
23	to	to	IN	_	22	prep	22:A2=PRD
24	job	job	NN	_	25	nn	_
25	losses	loss	NNS	_	23	pobj	_
26	in	in	IN	_	25	prep	_
27	Sweden	sweden	NNP	_	26	pobj	_
28	.	.	.	_	14	punct	_

1	Borg	borg	NNP	_	6	nsubj	6:A0
2	,	,	,	_	1	punct	_
3	Loof	loof	NNP	_	1	conj	_
4	and	and	CC	_	3	cc	_
5	Bjorklund	bjorklund	NNP	_	3	conj	_
6	said	say	VBD	pb=say.01	0	root	_
7	in	in	IN	_	6	prep	6:AM-LOC
8	a	a	DT	_	11	det	_
9	signed	sign	VBN	p2=JJ|pb=sign.02	11	amod	_
10	opinion	opinion	NN	_	11	nn	_
11	piece	piece	NN	_	7	pobj	9:A1=PPT
12	in	in	IN	_	11	prep	_
13	the	the	DT	_	16	det	_
14	Wall	wall	NNP	_	15	nn	_
15	Street	street	NNP	_	16	nn	_
16	Journal	journal	NNP	_	12	pobj	_
17	that	that	IN	p2=WDT	30	complm	_
18	the	the	DT	_	19	det	_
19	guarantees	guarantee	NNS	_	30	nsubj	20:A1=PPT;30:A1=PPT
20	offered	offer	VBN	pb=offer.01	19	partmod	_
21	by	by	IN	_	20	agent	20:A0=PAG
22	Pfizer	pfizer	NNP	_	21	pobj	_
23	over	over	IN	_	20	prep	20:AM-TMP
24	retaining	retain	VBG	pb=retain.01	23	pcomp	_
25	research	research	NN	_	24	dobj	24:A1=PPT
26	and	and	CC	_	25	cc	_
27	jobs	job	NNS	_	25	conj	_
28	in	in	IN	_	27	prep	_
29	Europe	europe	NNP	_	28	pobj	_
30	were	be	VBD	pb=be.01	6	ccomp	6:A1=PPT
31	not	not	RB	_	30	neg	30:AM-NEG
32	sufficient	sufficient	JJ	_	30	acomp	30:A2=PRD
33	.	.	.	_	6	punct	_

1	"	"	``	_	21	punct	_
2	If	if	IN	_	4	mark	_
3	there	there	EX	_	4	expl	_
4	is	be	VBZ	pb=be.02	0	root	_
5	no	no	DT	_	7	det	_
6	further	far	JJ	p2=RB	7	amod	_
7	clarity	clarity	NN	_	4	attr	4:A1=PPT
8	regarding	regard	VBG	_	7	prep	_
9	the	the	DT	_	10	det	_
10	effects	effect	NNS	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	Pfizer	pfizer	NNP	p2=NN	16	poss	_
13	's	's	POS	_	12	possessive	_
14	possible	possible	JJ	_	16	amod	_
15	semi-hostile	semi-hostile	JJ	_	16	amod	_
16	takeover	takeover	NN	_	11	pobj	_
17	of	of	IN	_	16	prep	_
18	AstraZeneca	astrazeneca	NNP	_	17	pobj	_
19	,	,	,	_	18	punct	_
20	our	our	PRP$	_	21	poss	_
21	conclusion	conclusion	NN	_	18	appos	_
22	...	..	.	_	4	punct	_

1	is	be	VBZ	pb=be.01	17	ccomp	17:A1=PPT
2	that	that	DT	p2=IN	8	complm	_
3	AstraZeneca	astrazeneca	NNP	_	5	poss	_
4	's	's	POS	_	3	possessive	_
5	owners	owner	NNS	_	8	nsubj	8:A0=PAG;9:A0=PAG
6	should	should	MD	_	8	aux	8:AM-MOD
7	seriously	seriously	RB	_	8	advmod	8:AM-MNR
8	consider	consider	VB	pb=consider.01	1	ccomp	1:A2=PRD
9	rejecting	reject	VBG	pb=reject.01	8	xcomp	8:A1
10	Pfizer	pfizer	NNP	_	12	poss	_
11	's	's	POS	_	10	possessive	_
12	proposal	proposal	NN	_	9	dobj	9:A1=PPT
13	,	,	,	_	17	punct	_
14	"	"	''	p2=``	17	punct	_
15	the	the	DT	_	16	det	_
16	ministers	minister	NNS	_	17	nsubj	17:A0
17	said	say	VBD	pb=say.01	0	root	_
18	.	.	.	_	17	punct	_

1	"	"	``	_	8	punct	_
2	Pfizer	pfizer	NNP	_	5	poss	_
3	's	's	POS	_	2	possessive	_
4	potential	potential	JJ	_	5	amod	_
5	takeover	takeover	NN	_	8	nsubjpass	8:A1=PPT
6	could	could	MD	_	8	aux	8:AM-MOD
7	be	be	VB	_	8	auxpass	_
8	interpreted	interpret	VBN	pb=interpret.01	0	root	_
9	as	as	IN	_	8	prep	8:A2=PRD
10	a	a	DT	_	11	det	_
11	sign	sign	NN	_	9	pobj	_
12	of	of	IN	_	11	prep	_
13	short	short	JJ	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	term	term	NN	_	16	nn	_
16	capitalism	capitalism	NN	_	12	pobj	_
17	,	,	,	_	11	punct	_
18	which	which	WDT	_	21	nsubj	21:R-A1
19	we	we	PRP	_	20	nsubj	20:A0=PAG
20	believe	believe	VBP	pb=believe.01	11	rcmod	_
21	is	be	VBZ	pb=be.01	20	ccomp	20:A1=PPT
22	not	not	RB	_	21	neg	21:AM-NEG
23	in	in	IN	_	21	prep	21:A2=PRD
24	the	the	DT	_	25	det	_
25	interest	interest	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	important	important	JJ	_	31	amod	_
28	life	life	NN	_	30	hmod	_
29	-	-	HYPH	_	30	hyph	_
30	science	science	NN	_	31	nn	_
31	research	research	NN	_	26	pobj	_
32	in	in	IN	_	31	prep	_
33	Sweden	sweden	NNP	_	32	pobj	_
34	,	,	,	_	21	punct	_
35	in	in	IN	_	16	prep	_
36	the	the	DT	_	37	det	_
37	UK	uk	NNP	_	35	pobj	_
38	or	or	CC	_	35	cc	_
39	elsewhere	elsewhere	RB	_	35	conj	_
40	.	.	.	_	8	punct	_
41	"	"	''	_	8	punct	_

1	Copyright	copyright	NN	p2=NNP	3	nn	_
2	Thomson	thomson	NNP	_	3	nn	_
3	Reuters	reuters	NNP	_	0	root	_
4	,	,	,	_	3	punct	_
5	2014	0	CD	_	3	appos	_
6	.	.	.	_	3	punct	_

